; 115 Stat. 748); (2) the controlled substance monitoring program under section 399O of the Public Health Service Act ( 42 U.S.C. 280g–3 ); (3) the Prescription Drug Overdose: Prevention for States program of the Centers for Disease Control and Prevention; (4) the Prescription Drug Overdose: Data-Driven Prevention Initiative of Centers for Disease Control and Prevention; (5) the Enhanced State Opioid Overdose Surveillance program of the Centers for Disease Control and Prevention; (6) the opioid grant program under section 1003 of the 21st Century Cures Act ( Public Law 114–255 ); and (7) the State Opioid Response Grant program described under the heading Substance abuse treatment under the heading Substance abuse and mental health services administration of title II of division H of the Consolidated Appropriations Act, 2018 ( Public Law 115–141 ). (d) Definitions In this section, the terms dispenser and practitioner have the meanings given such terms in section 102 of the Controlled Substances Act ( 21 U.S.C. 802 ). 8. Interoperability of certified health information technology Section 3001(c)(5) of the Public Health Service Act ( 42 U.S.C. 300jj–11(c)(5) ) is amended by adding at the end the following: (F) Interoperability Beginning on January 1, 2021, the National Coordinator shall not certify electronic health records as health information technology that is in compliance with applicable certification criteria under this paragraph unless such technology is interoperable with the prescription drug monitoring programs of each State that, at the time of the request for such certification, has such a program. . 9. Studies related to overdose discharge and follow-up policies (a) Study Not later than January 1, 2021, the Secretary of Health and Human Services shall— (1) conduct a study on the scope and circumstances of non-fatal opioid overdoses, the policies and procedures that States, health care systems, and first responders have implemented